World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
42010
World Ranking
12932
National Ranking
6611

David E. Moller publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David E. Moller sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 178 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David E. Moller D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David E. Moller sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

David E. Moller is affiliated with Eli Lilly in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these broader disciplines, their work has focused notably on Molecular Biology, Physiology, Surgery, Endocrinology, Diabetes and Metabolism, and Genetics.

The scientist's main topics of study include Metabolism, Diabetes, and Cancer; Pancreatic function and diabetes; Liver Disease Diagnosis and Treatment; Diet, Metabolism, and Disease; Peroxisome Proliferator-Activated Receptors; Adipose Tissue and Metabolism; and Diabetes Treatment and Management.

David E. Moller has contributed to a range of scientific publications, with recent papers including:

  • "Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes" (2020, Diabetes Obesity and Metabolism)
  • "Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action" (2021, PLoS ONE)
  • "Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis" (2021, Hepatology Communications)
  • "Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)" (2023, Journal of Hepatology)
  • "Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study" (2021, The Lancet. Gastroenterology & hepatology)

Frequent co-authors collaborating with David E. Moller include:

  • Sophie Hallakou-Bozec
  • Sébastien Bolze
  • Pascale Fouqueray
  • Pascale Gluais Dagorn
  • Pierre-Axel Monternier

Key publication venues where David E. Moller has appeared are:

  • Journal of Hepatology
  • Diabetes Obesity and Metabolism
  • PLoS ONE
  • Hepatology Communications
  • The Lancet. Gastroenterology & hepatology

David E. Moller has been recognized as a member of the Association of American Physicians.

Best Publications

  • Role of AMP-activated protein kinase in mechanism of metformin action

    Gaochao Zhou;Robert Myers;Ying Li;Yuli Chen

  • The Mechanisms of Action of PPARs

    Joel Berger;David E. Moller

  • New drug targets for type 2 diabetes and the metabolic syndrome

    David E. Moller

  • Fibroblast growth factor 21 corrects obesity in mice.

    Tamer Coskun;Holly A. Bina;Michael A. Schneider;James D. Dunbar

  • Insulin resistance--mechanisms, syndromes, and implications.

    David E. Moller;Jeffrey S. Flier

  • Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

    Nicolas Musi;Michael F. Hirshman;Jonas Nygren;Monika Svanfeldt

  • Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

    David E Moller

  • The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.

    Gregory Gaich;Jenny Y. Chien;Haoda Fu;Leonard C. Glass

  • Metabolic syndrome: a clinical and molecular perspective.

    David E Moller;Keith D Kaufman

  • Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization

    Terry P. Combs;John A. Wagner;Joel Berger;Tom Doebber

  • Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

    A Vidal-Puig;M Jimenez-Liñan;B B Lowell;A Hamann

  • Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.

    Hyunjung Lim;Rajnish A. Gupta;Wen Ge Ma;Bibhash C. Paria

  • Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.

    Bei Zhang;Gino Salituro;Deborah Szalkowski;Zhihua Li

  • Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes

    James Mu;John Woods;Yun-Ping Zhou;Ranabir Sinha Roy

  • Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2.

    Alex Elbrecht;Yuli Chen;Cathy A. Cullinan;Nancy Hayes

  • Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects

    Joel Berger;Mark D. Leibowitz;Thomas W. Doebber;Alex Elbrecht

  • Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

    Stacey L. Conarello;Zhihua Li;John Ronan;Ranabir Sinha Roy

  • Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.

    Bei Zhang;Joel Berger;Et-ding Hu;Deborah Szalkowski

  • Differential Regulation of Glucose Transport and Transporters by Glucose in Vascular Endothelial and Smooth Muscle Cells

    Nurit Kaiser;Shlomo Sasson;Edward P Feener;Nizza Boukobza-Vardi

  • Evidence Against Altered Expression of GLUT1 or GLUT4 in Skeletal Muscle of Patients With Obesity or NIDDM

    Oluf Pedersen;Jens F Bak;Per H Andersen;Sten Lund

Frequent Co-Authors

Jeffrey S. Flier
Jeffrey S. Flier Harvard University
Samuel D. Wright
Samuel D. Wright CSL (United States)
Stephen O'Rahilly
Stephen O'Rahilly University of Cambridge
Roy G. Smith
Roy G. Smith Scripps Research Institute
Laurie J. Goodyear
Laurie J. Goodyear Harvard University
Antonio Vidal-Puig
Antonio Vidal-Puig University of Cambridge
Arthur A. Patchett
Arthur A. Patchett MSD (United States)
Philipp E. Scherer
Philipp E. Scherer The University of Texas Southwestern Medical Center
Nancy A. Thornberry
Nancy A. Thornberry MSD (United States)
Alexei Kharitonenkov
Alexei Kharitonenkov Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking flexible or alternative options to traditional medical school, online degrees can provide a valuable pathway. In the rapidly changing healthcare landscape, numerous accredited programs now allow you to study from anywhere and advance your career.

Aspiring advanced practice nurses may consider the cheapest dnp online programs for a cost-effective route to a Doctor of Nursing Practice degree. If your interests align with pharmaceuticals, pursuing an online pharmacy degree can open doors to hands-on and research-based roles in medication management.

Those drawn to the intersection of technology and healthcare will find valuable opportunities through online schools for health information management. This field is essential for maintaining and securing patient records. If you are seeking entry-level positions with rapid training, explore online medical billing and coding courses, which prepare you for vital roles in healthcare administration.

These online pathways can help you start or advance your career in medicine and healthcare—while offering flexible, affordable learning options.

Best Scientists Citing David E. Moller

Trending Scientists